Staff turnover in EUR309,657378,027328,001415,248468,553
Staff turnover in EUR309,657378,027328,001415,248468,553
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)92.2092.2092.20140.8792.20
Dividend per share1.51.51.61.621.64
Basic earnings per share1.382.491.542.353.56
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover1,038.91,333.31,191.31,541.41,887.8
Operating income (EBIT)243.5441.1274.7416.9631.9
Earnings before taxes242.3440.3271.9413.1627.8
Annual net profit/ loss193.8349.5216.8329.9500.3
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets690.3878.7825.31,016.41,344.3
Total fixed assets423.7624.9621.1619.2679.0
Total assets1,114.01,503.61,446.41,635.62,023.3
Liabilities
Total short-term liabilities209.1275.3264.8273.4560.3
Total long-term liabilities157.0320.2291.5357.2178.5
Total provisions5.33.64.63.33.2
Equity capital747.9908.1890.11,005.01,284.5
Total liabilities1,114.01,503.61,446.41,635.62,023.3
Management:
Liisa Hurme
Hao Pan
Juhani Kankaanpää
Julia Macharey
Mikko Kemppainen
Niclas Lindstedt
Outi Vaarala
René Lindell
Satu Ahomäki
Board:
Veli-Matti Johannes Mattila
Ari Tapio Lehtoranta
Hilpi Rautelin
Sophie Papa
Henrik Stenqvist
Karen Sörensen
Kari Jussi Aho
Minna Maasilta
Shareholding in %:
Address: Orionintie 1A, 02200 Espoo
T: +358-10-4261
F: +
I: http://www.orionpharma.com
E: